Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > FLG(Gene name) > Human
  • Add your favorite
  • FLG (Gene name),
  • Filaggrin (Protein name ),  FILA_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    FLG;
    Protein name:
    Filaggrin;
    Alternative:

    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    N/A
    Function:
    Aggregates keratin intermediate filaments and promotes disulfide-bond formation among the intermediate filaments during terminal differentiation of mammalian epidermis.
    Subcellular Location:
    N/A
    Protein Attributes:
    Sequence length:
    4061
    Sequence:
    50:
    MSTLLENIFA | IINLFKQYSK | KDKNTDTLSK | KELKELLEKE | FRQILKNPDD | 
    100:
    PDMVDVFMDH | LDIDHNKKID | FTEFLLMVFK | LAQAYYESTR | KENLPISGHK | 
    150:
    HRKHSHHDKH | EDNKQEENKE | NRKRPSSLER | RNNRKGNKGR | SKSPRETGGK | 
    200:
    RHESSSEKKE | RKGYSPTHRE | EEYGKNHHNS | SKKEKNKTEN | TRLGDNRKRL | 
    250:
    SERLEEKEDN | EEGVYDYENT | GRMTQKWIQS | GHIATYYTIQ | DEAYDTTDSL | 
    300:
    LEENKIYERS | RSSDGKSSSQ | VNRSRHENTS | QVPLQESRTR | KRRGSRVSQD | 
    350:
    RDSEGHSEDS | ERHSGSASRN | HHGSAWEQSR | DGSRHPRSHD | EDRASHGHSA | 
    400:
    DSSRQSGTRH | AETSSRGQTA | SSHEQARSSP | GERHGSGHQQ | SADSSRHSAT | 
    450:
    GRGQASSAVS | DRGHRGSSGS | QASDSEGHSE | NSDTQSVSGH | GKAGLRQQSH | 
    500:
    QESTRGRSGE | RSGRSGSSLY | QVSTHEQPDS | AHGRTGTSTG | GRQGSHHEQA | 
    550:
    RDSSRHSASQ | EGQDTIRGHP | GSSRGGRQGS | HHEQSVNRSG | HSGSHHSHTT | 
    600:
    SQGRSDASHG | QSGSRSASRQ | TRNEEQSGDG | TRHSGSRHHE | ASSQADSSRH | 
    650:
    SQVGQGQSSG | PRTSRNQGSS | VSQDSDSQGH | SEDSERWSGS | ASRNHHGSAQ | 
    700:
    EQSRDGSRHP | RSHHEDRAGH | GHSADSSRKS | GTRHTQNSSS | GQAASSHEQA | 
    750:
    RSSAGERHGS | RHQLQSADSS | RHSGTGHGQA | SSAVRDSGHR | GSSGSQATDS | 
    800:
    EGHSEDSDTQ | SVSGHGQAGH | HQQSHQESAR | DRSGERSRRS | GSFLYQVSTH | 
    850:
    KQSESSHGWT | GPSTGVRQGS | HHEQARDNSR | HSASQDGQDT | IRGHPGSSRR | 
    900:
    GRQGSHHEQS | VDRSGHSGSH | HSHTTSQGRS | DASRGQSGSR | SASRTTRNEE | 
    950:
    QSRDGSRHSG | SRHHEASSHA | DISRHSQAGQ | GQSEGSRTSR | RQGSSVSQDS | 
    1000:
    DSEGHSEDSE | RWSGSASRNH | RGSAQEQSRH | GSRHPRSHHE | DRAGHGHSAD | 
    1050:
    SSRQSGTPHA | ETSSGGQAAS | SHEQARSSPG | ERHGSRHQQS | ADSSRHSGIP | 
    1100:
    RRQASSAVRD | SGHWGSSGSQ | ASDSEGHSEE | SDTQSVSGHG | QDGPHQQSHQ | 
    1150:
    ESARDWSGGR | SGRSGSFIYQ | VSTHEQSESA | HGRTRTSTGR | RQGSHHEQAR | 
    1200:
    DSSRHSASQE | GQDTIRAHPG | SRRGGRQGSH | HEQSVDRSGH | SGSHHSHTTS | 
    1250:
    QGRSDASHGQ | SGSRSASRQT | RKDKQSGDGS | RHSGSRHHEA | ASWADSSRHS | 
    1300:
    QVGQEQSSGS | RTSRHQGSSV | SQDSDSERHS | DDSERLSGSA | SRNHHGSSRE | 
    1350:
    QSRDGSRHPG | FHQEDRASHG | HSADSSRQSG | THHTESSSHG | QAVSSHEQAR | 
    1400:
    SSPGERHGSR | HQQSADSSRH | SGIGHRQASS | AVRDSGHRGS | SGSQVTNSEG | 
    1450:
    HSEDSDTQSV | SAHGQAGPHQ | QSHKESARGQ | SGESSGRSRS | FLYQVSSHEQ | 
    1500:
    SESTHGQTAP | STGGRQGSRH | EQARNSSRHS | ASQDGQDTIR | GHPGSSRGGR | 
    1550:
    QGSYHEQSVD | RSGHSGYHHS | HTTPQGRSDA | SHGQSGPRSA | SRQTRNEEQS | 
    1600:
    GDGSRHSGSR | HHEPSTRAGS | SRHSQVGQGE | SAGSKTSRRQ | GSSVSQDRDS | 
    1650:
    EGHSEDSERR | SESASRNHYG | SAREQSRHGS | RNPRSHQEDR | ASHGHSAESS | 
    1700:
    RQSGTRHAET | SSGGQAASSQ | EQARSSPGER | HGSRHQQSAD | SSTDSGTGRR | 
    1750:
    QDSSVVGDSG | NRGSSGSQAS | DSEGHSEESD | TQSVSAHGQA | GPHQQSHQES | 
    1800:
    TRGQSGERSG | RSGSFLYQVS | THEQSESAHG | RTGPSTGGRQ | RSRHEQARDS | 
    1850:
    SRHSASQEGQ | DTIRGHPGSS | RGGRQGSHYE | QSVDSSGHSG | SHHSHTTSQE | 
    1900:
    RSDVSRGQSG | SRSVSRQTRN | EKQSGDGSRH | SGSRHHEASS | RADSSRHSQV | 
    1950:
    GQGQSSGPRT | SRNQGSSVSQ | DSDSQGHSED | SERWSGSASR | NHLGSAWEQS | 
    2000:
    RDGSRHPGSH | HEDRAGHGHS | ADSSRQSGTR | HTESSSRGQA | ASSHEQARSS | 
    2050:
    AGERHGSHHQ | LQSADSSRHS | GIGHGQASSA | VRDSGHRGYS | GSQASDSEGH | 
    2100:
    SEDSDTQSVS | AQGKAGPHQQ | SHKESARGQS | GESSGRSGSF | LYQVSTHEQS | 
    2150:
    ESTHGQSAPS | TGGRQGSHYD | QAQDSSRHSA | SQEGQDTIRG | HPGPSRGGRQ | 
    2200:
    GSHQEQSVDR | SGHSGSHHSH | TTSQGRSDAS | RGQSGSRSAS | RKTYDKEQSG | 
    2250:
    DGSRHSGSHH | HEASSWADSS | RHSLVGQGQS | SGPRTSRPRG | SSVSQDSDSE | 
    2300:
    GHSEDSERRS | GSASRNHHGS | AQEQSRDGSR | HPRSHHEDRA | GHGHSAESSR | 
    2350:
    QSGTHHAENS | SGGQAASSHE | QARSSAGERH | GSHHQQSADS | SRHSGIGHGQ | 
    2400:
    ASSAVRDSGH | RGSSGSQASD | SEGHSEDSDT | QSVSAHGQAG | PHQQSHQEST | 
    2450:
    RGRSAGRSGR | SGSFLYQVST | HEQSESAHGR | TGTSTGGRQG | SHHKQARDSS | 
    2500:
    RHSTSQEGQD | TIHGHPGSSS | GGRQGSHYEQ | LVDRSGHSGS | HHSHTTSQGR | 
    2550:
    SDASHGHSGS | RSASRQTRND | EQSGDGSRHS | GSRHHEASSR | ADSSGHSQVG | 
    2600:
    QGQSEGPRTS | RNWGSSFSQD | SDSQGHSEDS | ERWSGSASRN | HHGSAQEQLR | 
    2650:
    DGSRHPRSHQ | EDRAGHGHSA | DSSRQSGTRH | TQTSSGGQAA | SSHEQARSSA | 
    2700:
    GERHGSHHQQ | SADSSRHSGI | GHGQASSAVR | DSGHRGYSGS | QASDNEGHSE | 
    2750:
    DSDTQSVSAH | GQAGSHQQSH | QESARGRSGE | TSGHSGSFLY | QVSTHEQSES | 
    2800:
    SHGWTGPSTR | GRQGSRHEQA | QDSSRHSASQ | DGQDTIRGHP | GSSRGGRQGY | 
    2850:
    HHEHSVDSSG | HSGSHHSHTT | SQGRSDASRG | QSGSRSASRT | TRNEEQSGDG | 
    2900:
    SRHSGSRHHE | ASTHADISRH | SQAVQGQSEG | SRRSRRQGSS | VSQDSDSEGH | 
    2950:
    SEDSERWSGS | ASRNHHGSAQ | EQLRDGSRHP | RSHQEDRAGH | GHSADSSRQS | 
    3000:
    GTRHTQTSSG | GQAASSHEQA | RSSAGERHGS | HHQQSADSSR | HSGIGHGQAS | 
    3050:
    SAVRDSGHRG | YSGSQASDNE | GHSEDSDTQS | VSAHGQAGSH | QQSHQESARG | 
    3100:
    RSGETSGHSG | SFLYQVSTHE | QSESSHGWTG | PSTRGRQGSR | HEQAQDSSRH | 
    3150:
    SASQYGQDTI | RGHPGSSRGG | RQGYHHEHSV | DSSGHSGSHH | SHTTSQGRSD | 
    3200:
    ASRGQSGSRS | ASRTTRNEEQ | SGDSSRHSVS | RHHEASTHAD | ISRHSQAVQG | 
    3250:
    QSEGSRRSRR | QGSSVSQDSD | SEGHSEDSER | WSGSASRNHR | GSVQEQSRHG | 
    3300:
    SRHPRSHHED | RAGHGHSADR | SRQSGTRHAE | TSSGGQAASS | HEQARSSPGE | 
    3350:
    RHGSRHQQSA | DSSRHSGIPR | GQASSAVRDS | RHWGSSGSQA | SDSEGHSEES | 
    3400:
    DTQSVSGHGQ | AGPHQQSHQE | SARDRSGGRS | GRSGSFLYQV | STHEQSESAH | 
    3450:
    GRTRTSTGRR | QGSHHEQARD | SSRHSASQEG | QDTIRGHPGS | SRRGRQGSHY | 
    3500:
    EQSVDRSGHS | GSHHSHTTSQ | GRSDASRGQS | GSRSASRQTR | NDEQSGDGSR | 
    3550:
    HSWSHHHEAS | TQADSSRHSQ | SGQGQSAGPR | TSRNQGSSVS | QDSDSQGHSE | 
    3600:
    DSERWSGSAS | RNHRGSAQEQ | SRDGSRHPTS | HHEDRAGHGH | SAESSRQSGT | 
    3650:
    HHAENSSGGQ | AASSHEQARS | SAGERHGSHH | QQSADSSRHS | GIGHGQASSA | 
    3700:
    VRDSGHRGSS | GSQASDSEGH | SEDSDTQSVS | AHGQAGPHQQ | SHQESTRGRS | 
    3750:
    AGRSGRSGSF | LYQVSTHEQS | ESAHGRAGPS | TGGRQGSRHE | QARDSSRHSA | 
    3800:
    SQEGQDTIRG | HPGSRRGGRQ | GSYHEQSVDR | SGHSGSHHSH | TTSQGRSDAS | 
    3850:
    HGQSGSRSAS | RETRNEEQSG | DGSRHSGSRH | HEASTQADSS | RHSQSGQGES | 
    3900:
    AGSRRSRRQG | SSVSQDSDSE | AYPEDSERRS | ESASRNHHGS | SREQSRDGSR | 
    3950:
    HPGSSHRDTA | SHVQSSPVQS | DSSTAKEHGH | FSSLSQDSAY | HSGIQSRGSP | 
    4000:
    HSSSSYHYQS | EGTERQKGQS | GLVWRHGSYG | SADYDYGESG | FRHSQHGSVS | 
    4050:
    YNSNPVVFKE | RSDICKASAF | GKDHPRYYAT | YINKDPGLCG | HSSDISKQLG | 
    4061:
    FSQSQRYYYY | E
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    UniGene:
    MIM:
    String:
    KEGG:
    SMR:
    Uniprot:
     
    FOR
    ELISA Kit for Human Filaggrin
    Cat.:
    E1186m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Filaggrin
    Cat.:
    E1186h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Filaggrin
    Cat.:
    U1186h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human Filaggrin
    MSDS:
    Please sign in first.
    Polyclonal Antibody for Human Filaggrin
    Polyclonal Antibody for Human Filaggrin
    Cat.:
    P1186Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Filaggrin
    Monoclonal Antibody for Human Filaggrin
    Protein for Human Filaggrin
    Protein for Human Filaggrin

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    2. 2.
      "Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus."
      Presland R.B. , Haydock P.V. , Fleckman P. , Nirunsuksiri W. , Dale B.A.
      J. Biol. Chem.267:23772-23781(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-591;TISSUE SPECIFICITY
    3. 3.
      "Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21."
      McKinley-Grant L.J. , Idler W.W. , Bernstein I.A. , Parry D.A.D. , Cannizzaro L. , Croce C.M. , Huebner K. , Lessin S.R. , Steinert P.M.
      Proc. Natl. Acad. Sci. U.S.A.86:4848-4852(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2389-2804
    4. 4.
      "Identification of the amino terminus of human filaggrin using differential LC/MS techniques: implications for profilaggrin processing."
      Thulin C.D. , Walsh K.A.
      Biochemistry34:8687-8692(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 2741-2760 AND 3065-3084;N-TERMINAL PROCESSING
      tissue: Foreskin.
    5. 5.
      "Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis."
      Senshu T. , Kan S. , Ogawa H. , Manabe M. , Asaga H.
      Biochem. Biophys. Res. Commun.225:712-719(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CITRULLINATION
    6. 6.
      "Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations."
      Weidinger S. , Illig T. , Baurecht H. , Irvine A.D. , Rodriguez E. , Diaz-Lacava A. , Klopp N. , Wagenpfeil S. , Zhao Y. , Liao H. , Lee S.P. , Palmer C.N.A. , Jenneck C. , Maintz L. , Hagemann T. , Behrendt H. , Ring J. , Nothen M.M. , more...
      J. Allergy Clin. Immunol.118:214-219(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO ATOD2
    7. 7.
      "Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march."
      Marenholz I. , Nickel R. , Rueschendorf F. , Schulz F. , Esparza-Gordillo J. , Kerscher T. , Grueber C. , Lau S. , Worm M. , Keil T. , Kurek M. , Zaluga E. , Wahn U. , Lee Y.-A.
      J. Allergy Clin. Immunol.118:866-871(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO ATOD2
    8. 8.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN ICHTHYOSIS VULGARIS
    9. 9.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO ATOD2
    10. 10.
      "Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis."
      Nomura T. , Sandilands A. , Akiyama M. , Liao H. , Evans A.T. , Sakai K. , Ota M. , Sugiura H. , Yamamoto K. , Sato H. , Palmer C.N.A. , Smith F.J.D. , McLean W.H.I. , Shimizu H.
      J. Allergy Clin. Immunol.119:434-440(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO ATOD2
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter